Mark Rosenberg, Author at AskBio - Page 4 of 5

National Limb Girdle Muscular Dystrophy Conference Posted on August 30, 2019 (January 6, 2020) by Mark Rosenberg in Event
Viralgen Receives cGMP Certification from European Medicines Agency Posted on August 27, 2019 (May 28, 2020) by Mark Rosenberg in News
AskBio Applauds Pfizer’s Continuing Investments in Gene Therapy Posted on August 22, 2019 (May 28, 2020) by Mark Rosenberg in News
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio Posted on August 13, 2019 (May 28, 2020) by Mark Rosenberg in News
Selecta Biosciences Combines ImmTOR™ Platform with AskBio’s IndustryLeading Gene Therapy Platform in Strategic Partnership Posted on August 7, 2019 (May 28, 2020) by Mark Rosenberg in News
Statement: Pfizer Phase 1b Clinical Trial Results Posted on July 1, 2019 (March 29, 2021) by Mark Rosenberg in News
Parent Project Muscular Dystrophy, 25th Annual Conference Posted on June 25, 2019 (January 6, 2020) by Mark Rosenberg in Event
Newly Approved Spinal Muscular Atrophy Gene Therapy, Zolgensma®, Validates AskBio Gene Therapy Platform Posted on May 30, 2019 (May 28, 2020) by Mark Rosenberg in News
American Society of Gene & Cell Therapy, 22nd Annual Conference Posted on April 29, 2019 (January 6, 2020) by Mark Rosenberg in Event
Gene Therapy Panel (Alliance for Regenerative Medicine) Posted on April 23, 2019 (January 3, 2020) by Mark Rosenberg in Event